Neuronetics® Celebrates 100,000 Treatment Milestone for Southern California TMS Center

NEXT STORY
Predictmedix Announces Technology Deployment at Hockeyfest in Partnership With Jones Entertainment Group
PREV STORY
Black Diamond Therapeutics to Host Webcast Presentation of Data From Phase 1 Dose-Escalation Portion of MasterKey-01 Clinical Trial
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Apellis Provides 24-Month Update from Phase 1b Study of Pegcetacoplan in Patients with Geographic Atrophy

author_avatar
NASDAQ Market News

Chemiluminescence Immunoassay Analyzers Market Research Report by Product, by End-User, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19

author_avatar
NASDAQ Market News

Alignment Healthcare’s AVA® Technology Platform Powers More Than 1 Million Personalized Care Interactions to Date

author_avatar
NASDAQ Market News